8-K
Current Report
Moleculin Biotech, Inc. Filed Acc 0001437749-21-028903
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading mbrx20211215_8k.htm…